MAPT and memory impairment: A combined analysis of this miRNA pattern, previously associated with neurodegenerative disorders such as those leading to memory impairment, with measurements of p-tau and the Aβ-42/40 ratio was also able to correctly label and unambiguously diagnose patients with AD dementia in 98% of cases and distinguish them from healthy controls [169].